FDA Inspection
Coastal Contract Packaging, IncCoastal Contract Packaging, Inc – FDA Inspection, Mar 17, 2023
Record Details
This FDA Inspection record concerns Coastal Contract Packaging, Inc, with an inspection on March 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7beec1b1-7fab-4157-aa51-4793c376b10f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200274
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Coastal Contract Packaging, Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 11, 2026 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| March 22, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Coastal Contract Packaging, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.